No article text was recorded for this version.
spontaneous reporting bias
Version 2 of 269 papers94 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data
- Blog: Safety of antidepressants commonly used in 6–17-year-old children and adolescents: A disproportionality analysis from 2014–2023 on the basis of the FAERS database
- Blog: Risk of Congenital Anomalies Associated with Psychotropic Medications: A Review of Neonatal Reports in the FDA Adverse Event Reporting System (FAERS)
- Blog: A real-world pharmacovigilance study on cardiovascular adverse events of tisagenlecleucel using machine learning approach
- Blog: Real-World pharmacovigilance analysis of drug-related conjunctivitis using the FDA adverse event reporting system database
- Blog: Immune checkpoint inhibitors-related myocarditis in patients with cancer: an analysis of international spontaneous reporting systems
- Blog: Pharmacovigilance insights into drug-associated venous thromboembolism
- Blog: A Real‐World Pharmacovigilance Study of Fruquintinib Based on the <scp>FDA</scp> Adverse Event Reporting System ( <scp>FAERS</scp> ) Database
- Blog: Using disproportionality analysis to explore the association between periostitis and triazole antifungals in the FDA Adverse Event Reporting System Database
- Blog: Adverse drug events associated with tiotropium: a real-world pharmacovigilance study of FDA adverse event reporting system database
- Blog: Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
- Blog: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
- Blog: Adverse events reporting of edaravone: a real-world analysis from FAERS database
- Blog: Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
- Blog: The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database
- Blog: Immune Checkpoint Inhibitors-related Myocarditis in Patients With Cancer: an Analysis of International Spontaneous Reporting Systems
- Blog: AI Incident Monitoring through a Public Health Lens
- Blog: Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database
- Blog: Signal mining and analysis of trifluridine/tipiracil adverse events based on real-world data from the FAERS database
- Blog: Safety assessment of sapropterin dihydrochloride: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
- Blog: Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data
- Blog: Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safety
- Blog: Cardiovascular adverse events associated with targeted therapies for multiple myeloma: a pharmacovigilance study
- Blog: Development and validation of a clinical prediction model for osteonecrosis of the jaw in patients receiving zoledronic acid using FAERS and canadian databases
- Blog: The Impact of Tirzepatide on Cancer Development: a literature review
- Blog: Gastrointestinal adverse events associated with Lenvatinib versus Lenvatinib plus Pembrolizumab: A pharmacovigilance study in FDA adverse event reporting system
- Blog: Detect Adverse Drug Reactions for Drug Aspirin
- Blog: An Early Adverse Drug Event Detection Approach with False Discovery Rate Control
- Blog: Characterization of the Differential Adverse Event Rates by Race/Ethnicity Groups for HPV Vaccine by Integrating Data From Different Sources
- Blog: Cardiac adverse events associated with dual immune checkpoint inhibitors: a pharmacovigilance analysis from the FDA adverse event reporting system
- Blog: Population-scale patient safety data reveal inequalities in adverse events before and during COVID-19 pandemic
- Blog: Deep learning approaches for extracting adverse events and indications of dietary supplements from clinical text
- Blog: Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study
- Blog: Pharmacovigilance study on old drugs repurposed for rare diseases across different indications: the case of fenfluramine
- Blog: Trial of an Anti-inflammatory Agent (Indomethacin) in Low Back Pain with and without Radicular Involvement
- Blog: A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)
- Blog: Assessing Authenticity and Anonymity of Synthetic User-generated Content in the Medical Domain
- Blog: Decoding Ambrisentan's Risks: A Deep Dive into FAERS Data
- Blog: Perianesthetic dental injuries: analysis of incident reports
- Blog: Multitask Dyadic Prediction and Its Application in Prediction of Adverse Drug-Drug Interaction
- Blog: Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database
- Blog: FAIL: Analyzing Software Failures from the News Using LLMs
- Blog: Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database
- Blog: Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system
- Blog: Comprehensive safety assessment of donepezil: pharmacovigilance analysis based on the FDA adverse event reporting system
- Blog: Population-scale identification of differential adverse events before and during a pandemic
- Blog: A Drug Similarity-Based Bayesian Method for Early Adverse Drug Event Detection
- Blog: Investigating the Detection of Adverse Drug Events in a UK General Practice Electronic Health-Care Database
- Blog: Real-world database evaluation of drug-associated vitreous opacities and machine learning for clinical interpretability
- Blog: Developing EMR-based algorithms to Identify hospital adverse events for health system performance evaluation and improvement: Study protocol
- Blog: Postmarket Drug Surveillance Without Trial Costs: Discovery of Adverse Drug Reactions Through Large-Scale Analysis of Web Search Queries
- Blog: Association of the gallbladder or biliary diseases with dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
- Blog: A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database
- Blog: Robert W. Downing, 1931–2002
- Blog: The impact of tirzepatide on the development of pancreatitis: a literature review
- Blog: Quantifying the Severity of Adverse Drug Reactions Using Social Media: Network Analysis
- Blog: Adverse Events in Robotic Surgery: A Retrospective Study of 14 Years of FDA Data
- Blog: Semaglutide and diabetic retinopathy: an OHDSI network study
- Blog: Safety assessment of laronidase: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
- Blog: 3D Pharmacophoric Similarity improves Multi Adverse Drug Event Identification in Pharmacovigilance
Showing 60 of 69 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_spontaneous_reporting_bias_dd0f4161,
title = {spontaneous reporting bias},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/spontaneous-reporting-bias/rdr_dd0f416112ca4f4bb5af8e7d3d528790},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 2, frozen text):
@misc{lacuna_spontaneous_reporting_bias_dd0f4161_v2,
title = {spontaneous reporting bias},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/spontaneous-reporting-bias/rdr_dd0f416112ca4f4bb5af8e7d3d528790/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-21},
}